Leukocytapheresis for rheumatic disease.
Leukocytapheresis (LCAP) is an apheresis technique for depleting pathogenic leukocytes from the circulating blood to improve the condition of the patient. LCAP sensu lato has been applied for the treatment of various rheumatic diseases: other treatments include thoracic duct drainage, photopheresis, centrifugal LCAP, granulocytapheresis (GCAP) and filtration LCAP. Among these modalities, GCAP and filtration LCAP are most commonly used in Japan for two reasons; the equipment and procedure are simple and practical and adverse events are rare and minor. In this article, LCAP, in particular filtration LCAP, for the treatment of rheumatic diseases is reviewed.
Hidaka
Toshihiko
T
Internal Medicine I, National Defense Medical College, Tokorozawa, Saitama, Japan. kogen@me.ndmc.ac.jp
Suzuki
Kimihiro
K
D006801:Humans; D007937:Leukapheresis / Q000379:methods*; D012216:Rheumatic Diseases / Q000628:therapy*